The CRISPR gene-editing system has offered scientists a powerful tool for studying the effects of altering specific genes. Now, researchers at the Gladstone-UCSF Institute of Genomic Immunology have devised a CRISPR platform that allowed them to discover new roles of genes in human T cells, which they say could aid the design of better cellular immunotherapies.
